BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35487034)

  • 1. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis.
    Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L
    Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering Subtle Gait Deterioration in People with Early-Stage Multiple Sclerosis Using Inertial Sensors: A 2-Year Multicenter Longitudinal Study.
    Gervasoni E; Anastasi D; Di Giovanni R; Solaro C; Rovaris M; Brichetto G; Confalonieri P; Tacchino A; Carpinella I; Cattaneo D
    Sensors (Basel); 2023 Nov; 23(22):. PubMed ID: 38005634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.
    Adusumilli G; Lancia S; Levasseur VA; Amblee V; Orchard M; Wagner JM; Naismith RT
    PLoS One; 2018; 13(6):e0198178. PubMed ID: 29879144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
    J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.
    Filli L; Zörner B; Kapitza S; Reuter K; Lörincz L; Weller D; Sutter T; Killeen T; Gruber P; Petersen JA; Weller M; Linnebank M
    Neurology; 2017 Feb; 88(9):832-841. PubMed ID: 28148629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.
    Wanitschek A; Seebacher B; Muehlbacher A; Brenneis C; Ehling R
    Mult Scler Relat Disord; 2024 May; 85():105532. PubMed ID: 38452648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instrumentally assessed gait quality is more relevant than gait endurance and velocity to explain patient-reported walking ability in early-stage multiple sclerosis.
    Carpinella I; Gervasoni E; Anastasi D; Di Giovanni R; Tacchino A; Brichetto G; Confalonieri P; Rovaris M; Solaro C; Ferrarin M; Cattaneo D
    Eur J Neurol; 2021 Jul; 28(7):2259-2268. PubMed ID: 33864413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
    Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying gait impairment in multiple sclerosis using GAITRite technology.
    Sosnoff JJ; Weikert M; Dlugonski D; Smith DC; Motl RW
    Gait Posture; 2011 May; 34(1):145-7. PubMed ID: 21531562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
    Zörner B; Filli L; Reuter K; Kapitza S; Lörincz L; Sutter T; Weller D; Farkas M; Easthope CS; Czaplinski A; Weller M; Linnebank M
    Mult Scler; 2016 Oct; 22(11):1463-1475. PubMed ID: 26762672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability.
    Abasıyanık Z; Kahraman T; Ertekin Ö; Baba C; Özakbaş S
    Mult Scler Relat Disord; 2021 Apr; 49():102771. PubMed ID: 33493789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting responsiveness to fampridine in gait-impaired patients with multiple sclerosis.
    Filli L; Werner J; Beyer G; Reuter K; Petersen JA; Weller M; Zörner B; Linnebank M
    Eur J Neurol; 2019 Feb; 26(2):281-289. PubMed ID: 30171655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using perceptive computing in multiple sclerosis - the Short Maximum Speed Walk test.
    Behrens J; Pfüller C; Mansow-Model S; Otte K; Paul F; Brandt AU
    J Neuroeng Rehabil; 2014 May; 11():89. PubMed ID: 24886525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Gait Characteristics During and Immediately After the 6-Minute Walk Test in Persons With Multiple Sclerosis: A Systematic Review.
    Abasıyanık Z; Kahraman T; Veldkamp R; Ertekin Ö; Kalron A; Feys P
    Phys Ther; 2022 Jul; 102(7):. PubMed ID: 35358308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.